Q4 2025 · 13F-HR
NVP Associates, LLCholdings as filed
Filed 2026-02-17 · accession 0001545692-26-000002
$255.2M
Reported value
6
Positions
2025-12-31
Period end
The Brief · NVP Associates, LLC · Q4 2025
AI · grounded in 13F
NVP Associates, LLC established a new position in BLLN with an investment of $42.01M. This addition represents the fund's only position change for the period. The fund now manages a total of 6 positions with an AUM of $255.22M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 55287L101 | MBX | MBX BIOSCIENCES INC | $67.4M | 26.4% | 2,136,335 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $66.8M | 26.2% | 1,838,482 | Common | SOLE |
| 090168105 | BLLN | BILLIONTOONE INC | $42.0M | 16.5% | 513,330 | Common | SOLE |
| 68170A108 | OMDA | OMADA HEALTH INC | $39.9M | 15.6% | 2,531,000 | Common | SOLE |
| 87427V103 | TALK | TALKSPACE INC | $35.6M | 13.9% | 9,802,972 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE HOLD INC | $3.5M | 1.39% | 3,225,097 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.